Global Breast Biopsy Market , 2016–2024
A breast biopsy is a procedure used for the screening and diagnosis of breast cancer. This is not only limited to cancer but also other ailments of the breast such as a lump in the breast and others.
A breast biopsy is a procedure used for the screening and diagnosis of breast cancer. This is not only limited to cancer but also other ailments of the breast such as a lump in the breast and others.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Breast</strong> <strong>Biopsy</strong> <strong>Market</strong><br />
<strong>Global</strong> <strong>Breast</strong> <strong>Biopsy</strong> <strong>Market</strong>: Segmentation<br />
The global breast biopsy market can be segmented into its type, guidance, product and<br />
geography. On the basis of type, the global market is divided into open surgical breast biopsy<br />
and needle breast biopsy. The needle breast biopsy is subdivided further into core-needle<br />
biopsy, fine-needle aspiration, biopsy and vacuum-assisted biopsy and the open surgical breast<br />
biopsy can be further subdivided into excisional breast biopsy and incisional breast biopsy.<br />
Based on guidance, the global market is segregated into magnetic resonance-guided breast<br />
biopsy, ultrasound-guided breast biopsy, mammography-guided stereotactic breast biopsy, and<br />
others, which include thermography and PET. Based on product, the market is categorized into<br />
biopsy tables, biopsy needles, localization wires, guidance systems and others, which include<br />
punches, markers, and sutures. Diversification on the basis of the region is seen into North<br />
America, Latin America, Europe, Asia-Pacific, and the Middle East and Africa.<br />
Request Report TOC (Table of Contents) @<br />
https://www.zionmarketresearch.com/toc/breast-biopsy-market<br />
<strong>Global</strong> <strong>Breast</strong> <strong>Biopsy</strong> <strong>Market</strong>: Growth Factors<br />
The global breast biopsy market is a growing market owing to factors such as higher incidence<br />
of breast cancer among post-menopausal women, increasing level of awareness, rising geriatric<br />
women’s population and developments made in technology. In addition, regions showing a<br />
higher female population would be a potential market for breast cancer diagnosis. The<br />
requirement for technologically advanced machinery and highly qualified surgeons, doctors and<br />
other medical team adds up to the high cost of biopsy surgery, which acts as a restraint to the<br />
market growth. Additionally, other factors include substandard healthcare facilities and limited